Related Articles
Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non‑small cell lung cancer: A network meta‑analysis
Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer
E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib
Efficacy of chemotherapy plus gefitinib treatment in advanced non‑small‑cell lung cancer patients following acquired resistance to gefitinib
Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma